JW Shinyak Corporation Market Cap ($61.80 Million)
Market Cap & Net Worth: JW Shinyak Corporation (067290)
JW Shinyak Corporation market cap. JW Shinyak Corporation (KQ:067290) has a market capitalization of $61.80 Million (₩91.20 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20879 globally and #1185 in its home market, demonstrating a -4.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JW Shinyak Corporation's stock price ₩2195.00 by its total outstanding shares 41547700 (41.55 Million). Also see JW Shinyak Corporation cash conversion from operations for how efficiently the company converts equity into cash flow.
JW Shinyak Corporation Market Cap History (2015–2026)
JW Shinyak Corporation market cap history from 2015 to 2026. Data shows change from $189.17 Million to $61.80 Million (-7.73% CAGR). Check JW Shinyak Corporation stock quote for real-time trading data and today's change.
Index Memberships
JW Shinyak Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$203.83 Billion | 0.03% | #529 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$203.83 Billion | 0.03% | #529 of 1384 |
Weight: JW Shinyak Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JW Shinyak Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JW Shinyak Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore JW Shinyak Corporation (067290) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
JW Shinyak Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
JW Shinyak Corporation's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $189.17 Million | $76.95 Billion | $255.85 Million | 0.00x | 0.74x |
| 2016 | $180.85 Million | $83.38 Billion | -$481.75 Million | 0.00x | N/A |
| 2017 | $191.58 Million | $76.84 Billion | -$6.08 Billion | 0.00x | N/A |
| 2018 | $151.58 Million | $91.78 Billion | -$7.51 Billion | 0.00x | N/A |
| 2019 | $111.11 Million | $102.53 Billion | $1.44 Billion | 0.00x | 0.08x |
| 2020 | $145.69 Million | $103.80 Billion | -$6.45 Billion | 0.00x | N/A |
| 2021 | $103.18 Million | $100.97 Billion | $883.78 Million | 0.00x | 0.12x |
| 2022 | $97.34 Million | $102.71 Billion | $1.40 Billion | 0.00x | 0.07x |
| 2023 | $69.83 Million | $104.23 Billion | -$37.36 Billion | 0.00x | N/A |
| 2024 | $42.49 Million | $93.01 Billion | $5.08 Billion | 0.00x | 0.01x |
Competitor Companies of 067290 by Market Capitalization
Companies near JW Shinyak Corporation in the global market cap rankings as of November 4, 2026. Also see 067290 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to JW Shinyak Corporation by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5272 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.49 Billion | ₩171400.00 |
| #8989 | ST Pharm Co.Ltd | KQ:237690 | $902.70 Million | ₩71400.00 |
| #9557 | NatureCell Co.Ltd | KQ:007390 | $793.12 Million | ₩22050.00 |
| #10371 | Oscotec Inc | KQ:039200 | $674.16 Million | ₩35400.00 |
Market Capitalization of JW Shinyak Corporation (2015–2026)
Market capitalization of JW Shinyak Corporation from 2015 to today. Between 2015 and today, JW Shinyak Corporation's market cap moved from $189.17 Million to $ 61.80 Million, with a yearly change of -7.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩61.80 Million | +3.05% |
| 2025 | ₩59.97 Million | +41.15% |
| 2024 | ₩42.49 Million | -39.15% |
| 2023 | ₩69.83 Million | -28.26% |
| 2022 | ₩97.34 Million | -5.66% |
| 2021 | ₩103.18 Million | -29.18% |
| 2020 | ₩145.69 Million | +31.13% |
| 2019 | ₩111.11 Million | -26.70% |
| 2018 | ₩151.58 Million | -20.88% |
| 2017 | ₩191.58 Million | +5.93% |
| 2016 | ₩180.85 Million | -4.40% |
| 2015 | ₩189.17 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of JW Shinyak Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $61.80 Million USD |
| MoneyControl | $61.80 Million USD |
| MarketWatch | $61.80 Million USD |
| marketcap.company | $61.80 Million USD |
| Reuters | $61.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JW Shinyak Corporation
JW Shinyak Corporation, a pharmaceutical company, engages in the production and sale of medicines and medical supplies in South Korea. The company offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesi… Read more